ResearchMoz

Global Photoelectric Sensor Market 2011-2015

Technavio
Published Date » 2012-10-19
No. Of Pages » 34
   
 TechNavio's analysts forecast the Global Photoelectric Sensor market to grow at a CAGR of 1.87 percent over the period 211-215. One of the key factors contributing to this market growth is the increasing focus on automation. The Global Photoelectric Sensor market has also been witnessing the increasing adoption of photoelectric sensors in Defense and IT sectors. However, the recession in the economy could pose a challenge to the growth of this market.  
   
 TechNavio's report, the Global Photoelectric Sensor Market 211-215, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Photoelectric Sensor market landscape and its growth prospects in the...
Table of Content

1. Executive Summary

2. Introduction

3. Market Coverage
Market Overview
Key Offerings

4. Market Landscape
4.1 Market Size and Forecast
4.2 Five Forces Analysis

5. Geographical Segmentation

6. Vendor Landscape

7. Buying Criteria

8. Market Growth Drivers

9. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis
13.1 Banner Engineering Corp.
Business Overview
SWOT Analysis
13.2 ifm Efector Inc.
Business Overview
SWOT Analysis
13.3 OMRON Corp.
Business Overview
SWOT Analysis
13.4 Sick AG
Business Overview
SWOT Analysis

14. Other Reports in this Series

List of Tables

NA

List of Figures


Exhibit 1: Global Sensor Market by Product Segmentation 2011-2015 (US$ billion)
Exhibit 2: Global Photoelectric Sensor Market 2011-2015 (US$ billion)
Exhibit 3: Global Photoelectric Sensor Market by Geographical Segmentation 2011

Upcoming Reports:

Syrup Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Syrup is a thick mixture of water and sugar usually flavored or medicated, or the accumulated juice of a fruit or plant. Syrups are mainly used in the food and beverage industries, as well as pharmaceutical industry. Most common types of syrups are Beverages, corn, fruit, maple, table (or pancake), toppings, candy, medicines. Syrups are not only used for adding sweetness to food items but they also provide flavor, by allowing flavor to stay on tongue for longer period. Syrups are used as natural preservative to reduce water activity. Syrups are also used in medicines to make them...
Fluorspar Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Fluorspar is the commercial name for the mineral fluorite (calcium fluoride CaF2). Commercially fluorspar is graded according to quality and attributes into acid grade, ceramic grade and metallurgical grade. It generally develops well formed cubic crystals exhibiting a wide range of colors. The end use is determined by the grade of the fluorspar. Almost two thirds of the world’s production of fluorspar is used for the manufacturing of hydrofluoric acid (HF). Hydrofluoric acid is used as a feedstock for the manufacturing of fluorine containing compounds like fluoropolymers and...
Central Nervous System (CNS) Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Biomarkers are used to indicate the biological state of a process, pathogenic process or therapeutic action.  Biomarkers facilitate understanding the development of a chronic disease, relationship between exposure to environmental chemicals and identification of subgroups of people who are relatively at high risk of developing disease. Continued development in related technologies such as genomics, proteomics and imaging system has accelerated the development of biomarkers. With the complexity of Central Nervous System (CNS), it is considered that biomarkers will play a vital...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...